Medtronic (MDT) Evolut TAVR System Shows Strong Performance at Two Years in Low Risk Trial

Article Related Press Releases (1) Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 5/24/2022

1. SPY
2. SNAP
3. ZM
4. HIVE
5. CRM

6. TWTR
7. FB
8. ALB
9. QQQ
10. BBY

Top News Most Read Special Reports

S&P 500, Nasdaq slide as weak economic data, dire outlooks stoke recession fears
'Snap Drops a Bomb': Snap (SNAP) Stock Crashes Nearly 30% on Forecast Cut, Musk-Twitter Saga to Get a 'Whole Lot More Interesting' Says Analyst
Bill Ackman Says Fed Must Aggressively Raise Rates Now to Combat Inflation or Economy Will Collapse
Intuit Shares Gain 3% on Q3 Earnings Beat and Raise
After-Hours Stock Movers 05/24: Wendy's Gains on Possible Peltz Deal, Nordstrom Up Following Earnings (more...)

Go back to Medtronic (MDT) Evolut TAVR System Shows Strong Performance at Two Years in Low Risk Trial

Medtronic Inc. (NYSE: MDT)						Delayed: 105.59 +1.33 (1.28%)
Previous Close	$104.26		52 Week High	$89.27
Open	$104.14		52 Week Low	$71.03
Day High	$105.73		P/E	30.00
Day Low	$103.76		EPS	$3.52
Volume	4,381,891